Valuation: DexCom, Inc.

Market Cap 29.81B 26.73B 24.63B 22.37B 42.34B 2,795B 43.52B 295B 118B 1,497B 112B 109B 4,733B P/E 2026 *
31.4x
P/E 2027 * 26.5x
Enterprise Value 29.46B 26.42B 24.35B 22.11B 41.85B 2,762B 43.02B 292B 116B 1,480B 111B 108B 4,679B EV / Sales 2026 *
5.64x
EV / Sales 2027 * 5.01x
Free-Float
90.14%
Yield 2026 *
-
Yield 2027 * -
1 day-1.42%
1 week-3.68%
Current month-2.88%
1 month-4.98%
3 months-8.82%
6 months+31.86%
Current year+20.42%
1 week 79.18
Extreme 79.18
90.25
1 month 76.52
Extreme 76.52
90.25
Current year 56.72
Extreme 56.72
92.59
1 year 56.72
Extreme 56.72
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/30/26 A Don

Director

-2,389 0.0006%
10/27/26 A Sell

Head of Human Resources

-2,565 0.0007%
10/15/26 A Sell

Compliance Officer

-1,700 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%-3.68%+45.73%-15.02% 29.81B
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 124B
-0.44%+4.42%-8.66%+18.52% 123B
-1.12%-1.85%-41.15%+5.00% 96.14B
+0.85%+2.41%-4.37%+76.50% 66.54B
-1.23%+7.29%+17.05%-9.39% 57.91B
-1.42%+3.66%-1.82%+62.49% 54.89B
+1.47%-2.27%-4.29%+54.83% 49.1B
+1.08%+3.41%+4.00%-4.71% 36.19B
Average -0.34%+1.79%+0.39%+24.95% 83B
Weighted average by Cap. -0.40%+2.16%-5.16%+26.05%

Financials

2026 *2027 *
Net sales 5.23B 4.69B 4.32B 3.92B 7.43B 490B 7.63B 51.74B 20.61B 263B 19.62B 19.21B 830B 5.77B 5.18B 4.77B 4.33B 8.2B 541B 8.43B 57.15B 22.77B 290B 21.67B 21.21B 917B
Net income 980M 879M 810M 735M 1.39B 91.87B 1.43B 9.7B 3.86B 49.22B 3.68B 3.6B 156B 1.14B 1.03B 945M 858M 1.62B 107B 1.67B 11.31B 4.51B 57.42B 4.29B 4.2B 182B
Net Debt -343M -308M -284M -258M -488M -32.2B -502M -3.4B -1.35B -17.25B -1.29B -1.26B -54.54B -888M -796M -734M -666M -1.26B -83.22B -1.3B -8.78B -3.5B -44.59B -3.33B -3.26B -141B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
10/11/26 $79.92 -1.42% 3,098,780
09/11/26 $81.07 +2.09% 4,099,334
06/11/26 $79.41 -5.98% 3,937,397
05/11/26 $84.46 -4.54% 4,922,769
04/11/26 $88.48 +6.64% 5,249,001
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
79.92USD
Average target price
98.58USD
Spread / Average Target
+23.34%
  1. Stock Market
  2. Stocks
  3. DXCM Stock